The Dow Jones Industrial Average tumbled more than 500 points on President Donald Trump’s recent threat of increases in China tariffs. In response to heightened control measures by China on rare earth exports, Trump hinted at a “massive” tariff upgrade. As a consequence, the S&P 500 was pushed to a 1.7% drop by midday, breaking a 33-day streak of stability. Additionally, the Nasdaq Composite fell by more than 2.5%, marking its most severe plunge since mid-April.
Trump’s comments had a particularly large impact on U.S.-listed shares of China-based firms which saw steep dips, with the iShares MSCI China ETF (MCHI) falling by more than 5%. Conversely, U.S.-based rare earth miners saw an increase in their stocks, as investors bet on heightened demand outside China.
Despite the sharp stock market drop, some investors are viewing this decline as a potential opportunity for investment, especially in technology companies. This is based on the presumption that the latest conflict between the U.S. and China may eventually deescalate.
In addition to the above, the stock market shifts also saw gains for companies like Applied Digital, seeing a rise of 16% due to artificial intelligence data center demand, and pharmaceutical company AstraZeneca after reaching an agreement with the Trump administration to cut drug prices in the U.S. On the other end, Chinese stocks like Alibaba, Baidu, JD.com, and PDD Holdings took a hit, with drops ranging from 5.2% to 8%.
Sources:
The stock market is diving on Trump’s threat of more China tariffs. Is this a good time to buy?
Dow tumbles 600 points as Trump’s remarks on China reignite trade war fears
Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports
We tested OpenAI’s Sora 2 video generator to find out why Hollywood is freaking out
Applied Digital stock climbs 16% as AI demand fuels data center growth
Chinese stocks slide as Trump threatens tariffs, accuses Beijing of holding world ‘captive’
Trump administration begins layoffs of federal workers amid government shutdown
Stocks making the biggest moves midday: MP Materials, Alibaba, Protagonist Therapeutics & more
How new federal tax changes for 2026 may affect families
Cramer spots opportunities in 2 overlooked stocks as markets drop on Trump remarks